Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antisense oligonucleotides against AChE in the treatment of gastrointestinal inflammation disorders

Antisense oligonucleotides against AChE in the treatment of gastrointestinal inflammation disorders

US Patent 8722876 · Granted May 13, 2014

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods for controlling seizures by manipulating the levels of microRNA-211 (miR2022
Hybrid nanoparticles as photoinitiators2021
Treatment of mood and stress related disorders2020
Hybrid nanoparticles as photoinitiators2019
Downregulating miR-132 for the treatment of lipid related disorders2019
Treatment of mood and stress related disorders2018
Acetylcholinesterase (ACHE)-derived peptide as an inducer of granulocytopoiesis,2010
Method for assessing trait anxiety by determining cholinergic status2009
Method for assessing trait anxiety by determining cholinergic status2009
Antisense oligonucleotide against human acetylcholinesterase (AChE) and uses the2008
Antisense oligonucleotide against human acetylcholinesterase (AChE) and uses the2006
Acetylcholinesterase-derived peptides and uses thereof2006